Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on...

* Reuters is not responsible for the content in this press release.

Fri Jun 26, 2009 9:30am EDT

Television News Segment Featuring Pyratine XR to Air to 18 Million +
Households on DIRECTV NewsCluster

- Bloomberg and CNN among stations to run 30-second spot on Pyratine XR(TM)
and Rosacea -

NAPA, Calif., June 26 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin
Board: SNKTY), a Life Sciences company engaged in the development of
technologies that target the science of healthy aging, announced today that on
June 27, 2009 at 7:19 AM Eastern Time, a 30-second segment on Pyratine XR(TM)
(0.125% furfuryl tetrahydropyranyl adenine) and rosacea, a condition
afflicting more than 14 million Americans, will be broadcast on DIRECTV's
NewsCluster.  The NewsCluster includes Bloomberg, CNBC, CNN, FOX News,
Headline News, MSNBC, Fox Business News, and The Weather Channel. 

DIRECTV is America's #1 satellite television service with more than 18 million
household viewers. The segment features a prominent board-certified
dermatologist who discusses a rosacea specific study conducted at the
Department of Dermatology, University of California, Irvine. Viewers are
directed to visit www.pyratinexr.com for further information.

Pyratine XR(TM) is marketed through select physicians in North America by
Senetek PLC and it was officially launched at the American Academy of
Dermatology's 67th Annual Meeting in San Francisco, March 6-10, 2009.

About Senetek, PLC
Senetek PLC (OTCBB: SNKTY) is a life sciences company engaged in the
development of breakthrough technologies that target the science of healthy
aging. The company's extensive research collaborations have resulted in a
strong pipeline of patented compounds and products with broad therapeutic
applications and a leading presence in dermatology.  Senetek collaborates with
established specialty pharmaceutical companies in the final development and
marketing of its proprietary products, most recently resulting in the
development of kinetin, the best-selling anti-aging product sold in the North
American physician market.  For more information, visit the company's website
at www.senetekplc.com.


SOURCE  Senetek PLC

William O'Kelly of Senetek, PLC, +1-707-226-3900, ext. 102; or Maggie Carr of
Michael Rogers Public Relations, +1-212-255-7210, ext. 22,
maggie@michaelrogerspr.com, for Senetek, PLC
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.